Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain

Several quantitative magnetic resonance (MR) measures are used to investigate multiple sclerosis (MS) in vivo. Precise quantitative investigation of the histopathological correlates of such measures has, to date, been limited. This study investigates the relationship of quantitative measures of myelin content, axonal density, and gliosis with quantitative MR measures in postmortem (PM) MS tissue. MR imaging (MRI) was performed on a 1.5T scanner and T1‐relaxation time (T1‐RT) and magnetization transfer ratio (MTR) maps were acquired in fresh PM brain of 20 MS subjects. Myelin content, axonal counts, and the extent of gliosis all were quantified using morphometric and digital imaging techniques. MRI and pathological data were in most cases coregistered using stereotactic navigation. Using multiple regression analysis, we detected significant correlations between myelin content (Trmyelin) and MTR (r = −0.84, p < 0.001) and myelin content and axonal count (−0.80, p < 0.001); MTR correlated with T1‐RT (r = −0.79, p < 0.001). No association was detected between the extent of gliosis and either MR measure. MTR was significantly higher in remyelinated than demyelinated lesions (means: 30.0 [standard deviation, 2.9] vs 23.8 [standard deviation, 4.3], p = 0.008). In conclusion, MTR is affected by myelin content in MS white matter. Ann Neurol 2004

[1]  L. S. King,et al.  OBSERVATIONS ON THE HISTOPATHOLOGY OF THE CEREBRAL LESIONS IN DISSEMINATED SCLEROSIS , 1936 .

[2]  K. Misulis,et al.  DEMYELINATING diseases. , 1952, Lancet.

[3]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.

[4]  P. J. Huber.  The behavior of maximum likelihood estimates under nonstandard conditions , 1967 .

[5]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[6]  Robert N. Holdefer,et al.  Quantitative immunocytochemistry using an image analyzer. I. Hardware evaluation, image processing, and data analysis , 1988, Journal of Neuroscience Methods.

[7]  G Johnson,et al.  Precise relaxation time measurements of normal‐appearing white matter in inflammatory central nervous system disease , 1989, Magnetic resonance in medicine.

[8]  D. N. Landon,et al.  Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. , 1990, Brain : a journal of neurology.

[9]  D.L. Plummer,et al.  DispImage: Un mezzo di analisi e presentazione per iconografia medica , 1992 .

[10]  E. Cho,et al.  Multiple sclerosis: Remyelination of nascent lesions: Remyelination of nascent lesions , 1993 .

[11]  E. Cho,et al.  Multiple sclerosis: remyelination of nascent lesions. , 1993, Annals of neurology.

[12]  J. Taubenberger,et al.  Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis , 1993, Annals of neurology.

[13]  A. MacKay,et al.  In vivo visualization of myelin water in brain by magnetic resonance , 1994, Magnetic resonance in medicine.

[14]  G. Barker,et al.  An interleaved sequence for accurate and reproducible clinical measurement of magnetization transfer ratio. , 1996, Magnetic resonance imaging.

[15]  S. Reingold,et al.  Defining the clinical course of multiple sclerosis , 1996, Neurology.

[16]  Hans Lassmann,et al.  Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology , 1997, Annals of neurology.

[17]  V. Perry,et al.  Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.

[18]  F. Barkhof,et al.  Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis , 1998, Neurology.

[19]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[20]  M. Bronskill,et al.  Characterizing white matter with magnetization transfer and T2 , 1999, Magnetic resonance in medicine.

[21]  F. Barkhof,et al.  Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability , 1999, Annals of neurology.

[22]  Gentleman,et al.  A comparison of manual and semi‐automated methods in the assessment of axonal injury , 1999, Neuropathology and applied neurobiology.

[23]  P. Valk,et al.  Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. , 2000 .

[24]  P M Matthews,et al.  Proton MR spectroscopy in multiple sclerosis. , 2000, Neuroimaging clinics of North America.

[25]  K P Whittall,et al.  Different magnetization transfer effects exhibited by the short and long T2 components in human brain , 2000, Magnetic resonance in medicine.

[26]  B K Rutt,et al.  Magnetization transfer and multicomponent T2 relaxation measurements with histopathologic correlation in an experimental model of MS , 2000, Journal of magnetic resonance imaging : JMRI.

[27]  W. Brück,et al.  Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. , 2000, Brain : a journal of neurology.

[28]  Nikos Evangelou,et al.  Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis , 2000, Annals of neurology.

[29]  C. D. DE GROOT,et al.  Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS , 2000, Neuropathology and applied neurobiology.

[30]  J Carpenter,et al.  Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. , 2000, Statistics in medicine.

[31]  I. V. Allen,et al.  Pathological abnormalities in the normal-appearing white matter in multiple sclerosis , 2001, Neurological Sciences.

[32]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[33]  R. Henkelman,et al.  Magnetization transfer in MRI: a review , 2001, NMR in biomedicine.

[34]  F Barkhof,et al.  Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. , 2001, Brain : a journal of neurology.

[35]  G J Parker,et al.  Accurate multislice gradient echo T1 measurement in the presence of non‐ideal RF pulse shape and RF field nonuniformity , 2001, Magnetic resonance in medicine.

[36]  P Kapeller,et al.  Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. , 2002, Brain : a journal of neurology.

[37]  Hompson,et al.  A LONGITUDINAL STUDY OF ABNORMALITIES ON MRI AND DISABILITY FROM MULTIPLE SCLEROSIS , 2002 .

[38]  M. Filippi,et al.  Inflammation in multiple sclerosis: the good, the bad, and the complex , 2002, The Lancet Neurology.

[39]  F Barkhof,et al.  The role of MRI as a surrogate outcome measure in multiple sclerosis , 2002, Multiple sclerosis.

[40]  Mark A. van Buchem,et al.  MT: magnetization transfer , 2003 .

[41]  G R Wayne Moore,et al.  MRI-clinical correlations: more than inflammation alone-what can MRI contribute to improve the understanding of pathological processes in MS? , 2003, Journal of the neurological sciences.

[42]  A. Thompson,et al.  New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes , 2003, Annals of neurology.

[43]  J. Frank,et al.  The role of nonconventional magnetic resonance imaging techniques in demyelinating disorders , 2003, Current neurology and neuroscience reports.

[44]  G J Barker,et al.  Quantitative magnetization transfer mapping of bound protons in multiple sclerosis , 2003, Magnetic resonance in medicine.

[45]  G. Moore.  MRI-clinical correlations: more than inflammation alone-what can MRI contribute to improve the understanding of pathological processes in MS? , 2003, Journal of the Neurological Sciences.

[46]  G J Barker,et al.  Stereotactic co‐registration of magnetic resonance imaging and histopathology in post‐mortem multiple sclerosis brain , 2003, Neuropathology and applied neurobiology.

[47]  Massimo Filippi,et al.  The use of quantitative magnetic-resonance-based techniques to monitor the evolution of multiple sclerosis , 2003, The Lancet Neurology.

[48]  Frederik Barkhof,et al.  Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. , 2003, Archives of neurology.

[49]  R. Ordidge,et al.  High field MRI correlates of myelin content and axonal density in multiple sclerosis , 2003, Journal of Neurology.

[50]  P. Tofts.  Quantitative MRI of the Brain , 2003 .

[51]  Moses Rodriguez.  A function of myelin is to protect axons from subsequent injury: implications for deficits in multiple sclerosis. , 2003, Brain : a journal of neurology.

[52]  G. Barker,et al.  Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[53]  Penny A. Gowland,et al.  T1: The Longitudinal Relaxation Time , 2004 .

[54]  M. Maier.  Quantitative MRI of the brain—measuring changes caused by disease , 2004 .

[55]  Rajiv Midha,et al.  MR properties of excised neural tissue following experimentally induced inflammation , 2004, Magnetic resonance in medicine.